Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces PSA levels by around 40-50% in BPH patients.

Topical minoxidil helps hair regrowth in over 50% of men and women.

Finasteride lowers risk of urinary issues and surgery by over 50% in 4 years.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Mnemonics help improve memory in dermatology by up to 50%.

Irradiating the whole central nervous system can lead to over 50% of patients with cerebellar medulloblastoma surviving three years.

Most American men experience hair loss by age 50, with limited effective treatments available and new options not expected soon.

Chemotherapy provides symptom relief and extends life in 30-50% of gynecological cancer cases, but has only cured choriocarcinoma.

Optimal transplant density for Chinese male hair loss patients is 35-50 hair/cm², with minimum 106.88 hair/cm² left in donor area for esthetic satisfaction.

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

Hair loss in women often starts in their late 20s and peaks after 50, and it's different from male hair loss.

Taking finasteride can partially improve oxygen levels in hospitalized male patients over 50 with COVID-19 pneumonia, but it doesn't affect other outcomes like death rate or hospital stay length.

The Total Excision Techniques improve hair transplant results by increasing grafts by at least 50% and reducing scarring.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

The VII International Congress of Dermocaribe in Colombia was a major dermatology event with over 50 lectures on various skin conditions and treatments.

Splitting one hair follicle into two can help regrow hair with a 50% to 70% success rate, useful when donor hair is limited.

Senescent alopecia is a type of hair loss that occurs after age 50, not caused by genetics, and involves a gradual thinning of hair without significant inflammation.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

Taking 1mg of finasteride daily for hair loss can lower PSA levels by 40-50%, so to keep PSA effective as a cancer screening tool, the PSA value should be doubled during treatment.

To prevent thinning in the donor area, harvest less than 50% of the original hair density in repeat hair transplants.

Hair loss in women is common, starts in late 20s, and affects 30% of women over 50.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Finasteride and dutasteride effectively stop or reverse hair loss in women with androgenetic alopecia, with dutasteride being more effective for women under 50.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Skin doctors should recognize and treat conditions like hair-pulling and skin-picking early, often using therapy and medication, to help 50-70% of patients.

A new treatment for hair loss was tested and most participants saw their hair loss stop within 2-8 weeks, with up to 50% more hair after 4 months, and no side effects.

Finasteride significantly reduces DHT levels in male dogs without affecting testosterone levels, suggesting it could be used to treat benign prostatic hypertrophy in dogs weighing 10 to 50 kilograms.

The document concludes that the human keratin gene cluster is complex, with a need for updated naming to reflect over 50 functional genes important for hair and skin biology.

About 40% of women without hair loss and 60% with hair loss experience a lot of hair shedding, especially those under 50 with long hair.